4Danesh J,Wheeler JG, Hirschfield GM ,ef al. C-reactive protein and othercirculating markers of inflammation in the prediction of coronary heartdisease[J]. N Engl J Med,2004;350( 14) : 1387-97.
5SuleimanM,Khatib R,Agmon Y, et al. Early inflammation and risk oflong-term development of heart failure and mortality in survivors of acutemyocardial infarction predictive role of C-reactive protein [ J ]. J Am CollCardiol,2006;47(5) :962-8.
6Ix JH,Shlipak MG,Chertow GMal. Association of cystatin C with mor-tality ,cardiovascular events and incident heart failure among persons withcoronary heart disease:data from the Heart and Soul Study [ J]. Circula-tion,2007 ; 115 (2) :173-9.
2Simons O, Grubb A, Thyself H. The blood serum con - cent ration of Cystitis C (gamma -trace) as a measure of the glomerular filtration rate [J]. Scand J Clint Lab Invest, 1985, 45 (2) : 97 - 101.
3Dharnidharka VR, Kwon G,Stevens G. Serum cystatin C is superior to serum ereatinine as amarker of kidney function:a meta-analysis [ J ]. Am J Kidney Dis,2002,40:221 - 227.
4McMahan CA,Gidding SS,McGill HC. Coronary heart disease risk factors and atherosclerosis in young people [ J ]. J Clin Lipidol, 2008,2(3) :118 - 126.
5Simonsen O, Grubb A ,Thysell H. The blood serum concentration of Cystatin C (gamma-trace) as a measure of the glomerular filtrationrate [J]. Scand J Clin Lab Invest,1985,45(2) :97 -101.
6Samak M J, Katz R,Stehman-Breon CO,et al. Cystotin C concentration as a risk factor for heart failure in older adults[J]. Ann Intern Mad ,2005,142 ( 7 ) :497 - 505.
7Laaksonen DE, Niskanen L, Punnonen K, et al. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol, 2003, 149: 601-608.
8Pradhan AD, Cook NR, Buring JE, et al. C-reactive protein is independently associated with fasting insulin in nondiabetic women.Arterioscler Thromb Vasc Biol, 2003, 23: 650-655.
9Freeman DJ, Norrie J, Caslake MJ, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes, 2002, 51: 1596-1600.
10Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med, 2002, 347: 1557-1565.
2Gijsberts CM,Gohar A,Ellenbroek GHJM,et al.Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography[J].Atherosclerosis,2015,241(1):234-240.
3Flores-Blanco PJ,Januzzi JL,Marin F,et al.Major bleeding risk prediction using chronic kidney disease epidemiology collaboration and modification of diet in renal disease equations in acute coronary syndrome[J].Eur J Clin Invest,2015,45(4):385-393.
4Doganer Y覶,Aydogan譈,Rohrer JE,et al.Comparison of estimated GFR equations based on serum cystatin C alone and in combination with serum creatinine in patients with coronary artery disease[J].Anatol J Cardiol,2015,15(7):571-576.
5Shafranskaya KS,Kashtalap VV,Gruzdeva OV,et al.The role of cystatin C in the prognosis of adverse outcomes after the coronary artery bypass graft surgery during hospitalisation[J].Heart Lung Circ,2015,24(2):193-199.
7LUERS C, SUTCLIFFE A, BINDER L, et al. NT-proANP and NT-proBNP as prognostic markers in patients with acute decompensated heart failure of different etiologies [J ]. Clin Biochem, 2013,46(12):1013-1019.
8CORTES R, PORTOLES M, ROSELLO-LLETIE, et al. Impact of glomerularfiltration rate on ufnary BNP and NT - pwBNP levels in heart flure[J]. Peptides, 2012, 33(2): 354-358.
